Metagenics, OmegaGenics EPA 1200, 60 Softgels

Metagenics OmegaGenics EPA 1200 is a practitioner-grade high-potency EPA-concentrated fish oil supplement providing 1,200 mg of eicosapentaenoic acid (EPA) per softgel from sustainably sourced sardines and anchovies, within a 1,430 mg fish oil base. Unlike standard combined EPA+DHA fish oils, OmegaGenics EPA 1200 is formulated as a high-EPA, low-DHA product -- making it specifically suited to applications where EPA's distinct physiological roles are the clinical priority. It is used to support cardiovascular health, help lower elevated serum triglycerides, reduce blood viscosity, help prevent atherosclerosis formation and progression, and modulate the body's inflammatory response.

Each softgel provides fish oil 1,430 mg yielding EPA 1,200 mg from sardine and anchovy. Non-medicinal ingredients: gelatin, glycerin, purified water, natural flavoring, mixed tocopherols (vitamin E as antioxidant stabilizer). EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are both long-chain omega-3 fatty acids but with distinct physiological roles. EPA is the primary substrate for producing Series-3 prostaglandins (anti-inflammatory eicosanoids), Series-5 leukotrienes (less inflammatory than those derived from arachidonic acid), and resolvin E-series compounds -- giving EPA a more direct role in modulating the acute inflammatory cascade than DHA. EPA is also the dominant omega-3 in triglyceride-lowering effects: the landmark REDUCE-IT trial (2018) used high-dose EPA (icosapentaenoic acid, 4g/day) to demonstrate a 25% reduction in major cardiovascular events, and EPA is the active compound in prescription omega-3 drugs (Vascepa) approved specifically for triglyceride reduction. At 1,200 mg EPA per softgel, two softgels daily provides 2,400 mg EPA -- a clinically relevant dose for cardiovascular and inflammatory support. Tocopherols prevent lipid oxidation, protecting the oil from rancidity during storage.

OmegaGenics EPA 1200 is particularly suited for adults with specific cardiovascular or inflammatory needs where high-dose EPA -- rather than a balanced EPA+DHA blend -- is the clinical objective. Key groups include: people with elevated serum triglycerides (hypertriglyceridemia) where high-dose EPA has the strongest evidence for reduction; individuals with cardiovascular disease or high cardiovascular risk who want to supplement at doses approaching those used in cardiovascular outcome trials; people with chronic inflammatory conditions (rheumatoid arthritis, inflammatory bowel disease, metabolic syndrome) where EPA's eicosanoid-modulating role is directly relevant; and individuals working with a healthcare practitioner who has recommended an EPA-concentrated omega-3 product specifically. Recommended dose: adults 2 softgels daily, or as directed by a healthcare practitioner. Taking with meals (preferably containing dietary fat) maximizes absorption. People taking anticoagulant medications (warfarin, clopidogrel, low-dose aspirin) should consult a physician before use, as high-dose EPA has antiplatelet activity that may interact. Surgery patients should discontinue 2 weeks prior to any surgical procedure. The 60-softgel bottle provides a 30-day supply at the standard 2-per-day dose.

Three verifiable distinctions. First, EPA concentration: at 1,200 mg EPA per softgel, OmegaGenics EPA 1200 provides more than twice the EPA of most standard high-dose fish oil softgels (which typically deliver 400-600 mg EPA per capsule in a combined formula). Two softgels provide 2,400 mg EPA, approaching the 2-4 g/day EPA range used in major cardiovascular clinical trials without requiring 6-8 standard fish oil capsules. Second, EPA-only focus: for specific clinical applications -- particularly triglyceride reduction and cardiovascular risk management -- EPA has a differentiated evidence profile from DHA. The REDUCE-IT trial demonstrated cardiovascular benefit from high-dose EPA specifically; DHA does not have an equivalent large trial. For practitioners targeting the EPA pathway specifically, a product that provides 84% of its omega-3 content as EPA (rather than 30-50% EPA in balanced fish oils) allows precise dosing of the therapeutic fatty acid. Third, Metagenics quality infrastructure: Metagenics is a practitioner-only supplement brand with USP GMP and NSF International GMP dual certification, a proprietary TruQuality batch traceability system with online verification access for each lot number, over 60,000 quality control tests conducted annually, and B Corp certification since 2022. This dual-GMP standard with batch-level online traceability is a verifiable quality commitment that exceeds standard supplement industry practice.

Metagenics is an American functional medicine supplement brand founded in 1983 by Dr. Jeffrey Bland, widely regarded as the father of functional medicine. Products address root causes of chronic illness rather than symptoms, targeting gut health, hormonal balance, detoxification, cardiometabolic health, and cognitive function. Manufacturing is USP GMP and NSF GMP certified, with over 60,000 quality control tests conducted annually. Metagenics is the number-one doctor-recommended professional supplement brand in North America and holds Certified B Corp status. Products are available through licensed healthcare practitioners.

Metagenics is a science-based supplement brand founded in 1983, with Canadian operations headquartered in Mississauga, Ontario. All Metagenics products sold in Canada carry Health Canada Natural Product Numbers (NPN), confirming they have been reviewed for safety, efficacy, and quality under Canada's Natural Health Products Regulations. Manufacturing facilities are audited by USP GMP, NSF International GMP, and Canada's Natural and Non-Prescription Health Products Directorate (NNHPD). Metagenics is also a certified B Corporation (since 2022) and offers lot-level quality transparency through its TruQuality® Guarantee, allowing customers to verify testing results for every formula by lot number.

Metagenics differs from typical retail supplements in three ways. First, it is a practitioner-grade brand — formulated for therapeutic use and traditionally distributed through licensed healthcare providers, not mass retail, making it the #1 Doctor Recommended Professional Supplement Brand in North America. Second, its formulas are built on nutrigenomics research — the science of how nutrition interacts with genes — backed by hundreds of clinical studies, with a focus on bioavailability-optimized ingredient forms rather than generic powders. Third, it maintains multi-layer independent quality verification: USP GMP, NSF GMP, and NNHPD Canada audits, with every formula's testing results accessible online by lot number via the TruQuality® Guarantee.

Metagenics was built around nutrigenomics — the science of how nutrients regulate gene expression — a field its founder Dr. Jeffrey Bland helped pioneer before it was mainstream. This underpins formulas designed to modulate biological pathways at the cellular level, not just correct deficiencies. Unlike brands that adopted practitioner distribution as a later marketing channel, Metagenics was practitioner-exclusive from inception, with clinical protocols as the core of product design. It has participated in hundreds of clinical trials and conducts over 60,000 quality control tests annually — a depth of evidence unusual for the supplement category.

Every Metagenics product undergoes rigorous testing at every stage of production, including raw ingredients, finished formulas, and final encapsulation. We don’t just meet industry standards—we exceed them.

While the FDA requires minimal oversight for supplements, we invest over $1.5 million annually into quality assurance. That includes nearly 50,000 tests per year conducted by more than 70 global quality experts to ensure purity, safety, and potency.

Each product is triple-tested for identity, strength, and consistency—so what’s on the label is exactly what’s in the bottle. And to hold ourselves to an even higher standard, we also voluntarily submit every product for third-party testing to confirm quality and transparency you can trust.